APPLICATIONS PUBLISHED 24 JULY 2002
Published: 1-Jan-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Amalgam substitute
3M Espe 1223911*
Orally disintegrating compsn comprising mirtazapine
Akzo Nobel 1223914*
Dry powder compsns having improved dispersivity
Inhale Therapeutic Systems 1223915*
Neutral-cationic lipid for nucleic acid and drug delivery
ALZA Corp 1223916*
Sustained release microspheres
Epic Therapeutics 1223917*
Pharmaceutical compsns comprising a HMG CoA reductase inhibitor
AstraZeneca 1223918*
Swellable delivery system
Universieit Leiden 1223919*
Edible MCC/PGA coating compsn
FMC Corp 1223920*
Tissue factor antagonists and methods of use thereof
Sunol Molecular Corp 1223921*
6-methoxy-2-naphthylacetic acid prodrugs for treating inflammation
Nobex Corp 1223922*
Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
Temple University of the Commonwealth System of Higher Education 1223923*
Use of CSAIDS in rhinovirus infection
SmithKline Beecham 1223924*
Use of a fatty acid derivative for the treatment of external secretion disorders
Sucampo 1223925*
6-methoxy-2-naphthylacetic acid prodrugs compsns for treating inflammation
Nobex Corp 1223926*
Use of retigabin for treating neuropathic pain
Viatris 1223927*
Use of flavones, coumarins and related compounds to treat infections
Prendergast, Patrick Thomas 1223928*
Cannabimimetic indole derivatives
The University of Connecticut 1223929*
Treatment of diskinesia
The Victoria University of Manchester 1223930*
Treatment of prevention of hypotension and shock
Orion Corp 1223931*
Compounds and methods
SmithKline Beecham 1223932*
5-membered heterocycle derivatives, production thereof as medicaments
Societe de Conseils de Recherches et d'Applications Scientifiques 1223933*
Combination therapy including camptothecin
SuperGen 1223934*
Methods of use of fluoroquinolone against bacteria
SmithKline Beecham 1223935*
Oral formulations for anti-tumour compounds
Pharmacia Italia 1223936*
Gene necessary for striatal function, uses thereof, and compounds for modulating same
Novaneuron 1223937*
Treatment of movement disorders by administration of 5-hydroxytryptamine receptor/(a)-2-adrenergic receptor antagonist compsns
Richter, Reed; Hultquist, Steven; Richter, Virginia; Giduz, Thomas 1223938*
Method of treating weight gain
AstraZeneca 1223939*
Treatment of osteoporosis
Orion Corp 1223940*
Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
Hollis-Eden Pharmaceuticals 1223941*
Agents for the enhanced oxygen delivery in mammals
GMP Companies 1223942*
Therapeutic use of an inhibitor or an antagonist of an ABC protein in bone
The University of Liverpool 1223943*
Thrombopoietin mimetics
SmithKline Beecham 1223944*
Compsns comprising oxophosphonate-based metalloproteinase inhibitors
Yissum Research Development Company of the Hebrew University of Jerusalem 1223945*
Human neuropeptide receptor
Huma Genome Sciences 1223946*
Targeted vectors
Canji 1223947*
Method of inhibiting NF-kappa-B with heparin, for treating cardiovascular diseases and inflammations
Charlotte-Mecklenburg Hospital 1223948*
Extended release formulations of erythromycin derivatives
Abbott Laboratories 1223949*
Ribozyme therapy for the treatment of proliferative skin and eye diseases
Immusol 1223950*
Method of preventing adhesions with absorbable polyoxaesters
Ethicon 1223951*
Methods for treatment of solid tumours and metastasis by gene therapy
Aguilar-Cordova 1223952*
Matrix-targeted fusion polypeptides for tissue regeneration and wound healing
University of Southern California 1223953*
Fibrin sealants providing less inflammatory response and methods using same
Bristol-Myers Squibb 1223955*
Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
Osiris Therapeutics 1223956*
A method of treating erectile dysfunction
Duke University 1223957*
